Anticholinergic Drug Use and Negative Outcomes Among the Frail Elderly Population Living in a Nursing Home

Journal of the American Medical Directors Association

Volumn 15, Issue 11, 2014, Pages 825-829

  Landi, Francesco ^a   Dell'Aquila, Giuseppina ^b   Collamati, Agnese ^a   Martone, Anna Maria ^a   Zuliani, Giovanni ^c   Gasperini, Beatrice ^d   Eusebi, Paolo ^e,f   Lattanzio, Fabrizia ^b   Cherubini, Antonio ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b INRCA   (Italy)

^c UNIVERSITY OF FERRARA   (Italy)

^d UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^e Regional Health Authority of Umbria   (Italy)

^f UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Anticholinergic medications; Delirium; Falls; Functional decline

Indexed keywords

AMANTADINE; AMITRIPTYLINE; ATROPINE; BENZATROPINE MESILATE; CARISOPRODOL; CHLORPHENIRAMINE MALEATE; CHLORPROMAZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CYPROHEPTADINE; DICYCLOVERINE; DIPHENHYDRAMINE; FLUPHENAZINE; HALOPERIDOL; HYDROXYZINE; HYDROXYZINE EMBONATE; HYOSCYAMINE; IMIPRAMINE; LEVODOPA; MECLOZINE; OXYBUTYNIN; PAROXETINE; PERPHENAZINE; PROMETHAZINE; QUETIAPINE; RISPERIDONE; THIORIDAZINE; TIOTIXENE; TIZANIDINE; TRIFLUOPERAZINE; UNINDEXED DRUG;

AGED; ANTICHOLINERGIC EFFECT; ANXIETY DISORDER; ARTICLE; COGNITIVE DEFECT; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DELIRIUM; DEPRESSION; DRUG USE; FEMALE; FOLLOW UP; FRAIL ELDERLY; FUNCTIONAL DISEASE; HEART FAILURE; HOSPITALIZATION; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; NURSING HOME; NURSING HOME PATIENT; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PARKINSON DISEASE; POPULATION; PREVALENCE; PROSPECTIVE STUDY; RISK FACTOR; SAMPLE SIZE; SCHIZOPHRENIA; VERY ELDERLY; CHEMICALLY INDUCED; CLINICAL TRIAL; FACTUAL DATABASE; FALLING; PSYCHOLOGY; TREATMENT OUTCOME;

ACCIDENTAL FALLS; AGED; AGED, 80 AND OVER; CHOLINERGIC ANTAGONISTS; DATABASES, FACTUAL; DELIRIUM; FEMALE; FRAIL ELDERLY; HUMANS; ITALY; MALE; NURSING HOMES; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84908223855     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2014.08.002     Document Type: Article

References (42)

1. Sinvani L.D., Beizer J., Akerman M., et al. Medication reconciliation in continuum of care transitions: A moving target. JAm Med Dir Assoc 2013, 14:668-672.
2. Desai R.J., Williams C.E., Greene S.B., et al. Exploratory evaluation of medication classes most commonly involved in nursing home errors. JAm Med Dir Assoc 2013, 14:403-408.
3. Onder G., Landi F., Liperoti R., et al. Impact of inappropriate drug use among hospitalized older adults. Eur J Clin Pharmacol 2005, 61:453-459.
4. Dilles T., Vander Stichele R.H., Van Bortel L.M., Elseviers M.M. The development and test of an intervention to improve ADR screening in nursing homes. JAm Med Dir Assoc 2013, 14:379.e1-379.e6.
5. Beers M.H. Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med 1997, 157:1531-1536.
6. García-Gollarte F., Baleriola-Júlvez J., Ferrero-López I., Cruz-Jentoft A.J. Inappropriate drug prescription at nursing home admission. JAm Med Dir Assoc 2012, 13:83.e9-83.e15.
7. Lowry E., Woodman R.J., Soiza R.L., Mangoni A.A. Associations between the anticholinergic risk scale score and physical function: Potential implications for adverse outcomes in older hospitalized patients. JAm Med Dir Assoc 2011, 12:565-572.
8. Ancelin M.L., Artero S., Portet F., et al. Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: Longitudinal cohort study. BMJ 2006, 332:455-459.
9. Aizenberg D., Sigler M., Weizman A., Barak Y. Anticholinergic burden and the risk of falls among elderly psychiatric inpatients: A 4-year case-control study. Int Psychogeriatr 2002, 14:307-310.
10. Morley J.E. Anticholinergic medications and cognition. JAm Med Dir Assoc 2011, 12:543-543.e1.
11. Rudolph J.L., Salow M.J., Angelini M.C., McGlinchey R.E. The anticholinergic risk scale and anticholinergic adverse effects in older persons. Arch Intern Med 2008, 168:508-513.
12. Luukkanen M.J., Uusvaara J., Laurila J.V., et al. Anticholinergic drugs and their effects on delirium and mortality in the elderly. Dement Geriatr Cogn Dis Extra 2011, 1:43-50.
13. Landi F., Lattanzio F., Dell'Aquila G., et al. Prevalence and potentially reversible factors associated with anorexia among older nursing home residents: Results from the ULISSE project. JAm Med Dir Assoc 2013, 14:119-124.
14. Cherubini A., Eusebi P., Dell'Aquila G., et al. Predictors of hospitalization in Italian nursing home residents: The U.L.I.S.S.E. project. JAm Med Dir Assoc 2012, 13:84.e5-84.e10.
15. Morris J., Hawes C., Murphy K., et al. Minimum Data Set Plus Training Manual 1991, Eliot Press, Natick, MA.
16. Landi F., Tua E., Onder G., et al. Minimum data set for home care: A valid instrument to assess frail older people living in the community. Med Care 2000, 38:1184-1190.
17. Landi F., Russo A., Danese P., et al. Anemia status, hemoglobin concentration, and mortality in nursing home older residents. JAm Med Dir Assoc 2007, 8:322-327.
18. Landi F., Liperoti R., Fusco D., et al. Sarcopenia and mortality among older nursing home residents. JAm Med Dir Assoc 2012, 13:121-126.
19. Dosa D., Intrator O., McNicoll L., et al. Preliminary derivation of a nursing home confusion assessment method based on data from the minimum data set. JAm Geriatr Soc 2007, 55:1099-1105.
20. Brown H., Prescott R. Applied Mixed Models in Medicine 2006, John Wiley & Sons, Chichester, England. 2nd ed.
21. Rubin D.B. Multiple Imputation for Nonresponse in Surveys 1987, John Wiley & Sons, Hoboken, NJ.
22. Schafer J.L. Analysis of Incomplete Multivariate Data 1997, Chapman and Hall, New York.
23. Kolanowski A., Fick D.M., Campbell J., et al. Apreliminary study of anticholinergic burden and relationship to a quality of life indicator, engagement in activities, in nursing home residents with dementia. JAm Med Dir Assoc 2009, 10:252-257.
24. Mulsant B.H., Pollock B.G., Kirshner M., et al. Serum anticholinergic activity in a community-based sample of older adults: Relationship with cognitive performance. Arch Gen Psychiatry 2003, 60:198-203.
25. West T., Pruchnicki M.C., Porter K., Emptage R. Evaluation of anticholinergic burden of medications in older adults. JAm Pharm Assoc 2013, 53:496-504.
26. Landi F., Russo A., Liperoti R., et al. Anticholinergic drugs and physical function among frail elderly population. Clin Pharmacol Ther 2007, 81:235-241.
27. Pasina L., Djade C.D., Lucca U., et al. Association of anticholinergic burden with cognitive and functional status in a cohort of hospitalized elderly: Comparison of the anticholinergic cognitive burden scale and anticholinergic risk scale: Results from the REPOSI study. Drugs Aging 2013, 30:103-112.
28. Wilson N.M., Hilmer S.N., March L.M., et al. Associations between drug burden index and falls in older people in residential aged care. JAm Geriatr Soc 2011, 59:875-880.
29. Tune L.E. Serum anticholinergic activity levels and delirium in the elderly. Semin Clin Neuropsychiatry 2000, 5:149-153.
30. Liperoti R., Landi F. The management of behavioral and psychological symptoms of dementia: The need for tailored interventions. JAm Med Dir Assoc 2013, 14:306-307.
31. Mangoni A.A., van Munster B.C., Woodman R.J., de Rooij S.E. Measures of anticholinergic drug exposure, serum anticholinergic activity, and all-cause postdischarge mortality in older hospitalized patients with hip fractures. Am J Geriatr Psychiatry 2013, 21:785-793.
32. Gnjidic D., Hilmer S.N., Hartikainen S., et al. Impact of high risk drug use on hospitalization and mortality in older people with and without Alzheimer's disease: A national population cohort study. PLoS One 2014, 9:e83224.
33. Beier M.T. Cholinesterase inhibitors and anticholinergic drugs: Is the pharmacologic antagonism myth or reality?. JAm Med Dir Assoc 2005, 6:413-414.
34. Lemay C.A., Mazor K.M., Field T.S., et al. Knowledge of and perceived need for evidence-based education about antipsychotic medications among nursing home leadership and staff. JAm Med Dir Assoc 2013, 14:895-900.
35. Luukkanen M.J., Uusvaara J., Laurila J.V., et al. Anticholinergic drugs and their effects on delirium and mortality in the elderly. JAm Geriatr Soc 2011, 59:S277-S281.
36. Onder G., Landi F., Cesari M., Investigators of the GIFA Study, et al. Inappropriate medication use among hospitalized older adults in Italy: Results from the Italian Group of Pharmacoepidemiology in the Elderly. Eur J Clin Pharmacol 2003, 59:157-162.
37. Ruggiero C., Lattanzio F., Dell'Aquila G., et al. Inappropriate drug prescriptions among older nursing-home residents: The Italian perspective. Drugs Aging 2009, 26:15-30.
38. Ruggiero C., Dell'Aquila G., Gasperini B., for the U.L.I.S.S.E.study group, et al. Potentially inappropriate drug prescriptions and risk of hospitalization among Italian older nursing home residents: The U.L.I.S.S.E. project on behalf of the ULISSE study group. Drug Aging 2010, 27:747-758.
39. Cestac P., Tavassoli N., Vellas B., Rolland Y. Improving medication use in the nursing homes: A European perspective. JAm Med Dir Assoc 2013, 14:6-9.
40. Tamura B.K., Bell C.L., Lubimir K., et al. Physician intervention for medication reduction in a nursing home: The polypharmacy outcomes project. JAm Med Dir Assoc 2011, 12:326-330.
41. Lapane K.L., Hughes C.M., Christian J.B., et al. Evaluation of the fleetwood model of long-term care pharmacy. JAm Med Dir Assoc 2011, 12:355-363.
42. Kersten H., Molden E., Tolo I.K., et al. Cognitive effects of reducing anticholinergic drug burden in a frail elderly population: A randomized controlled trial. JGerontol A Biol Sci Med Sci 2013, 68:271-278.